Understanding Prognosis: For Doctors, a Patient-Centered Approach
Understanding Prognosis: For Doctors, a Patient-Centered Approach
Anthony L. Back, M.D., coaches other oncologists about how to discuss prognosis with their patients. Communication, he says, is part of providing good care: "Talking to patients and their families about prognosis is complicated. But done well, these conversations promote trust, enable patients to plan, and strengthen healthy coping." Produced by the National Cancer Institute (NCI), this video is one of five in a series. To see the entire NCI Prognosis Video Series and to find other helpful information that can help patients and their healthcare teams talk about cancer prognosis, go to http://www.cancer.gov/prognosis. To learn about Dr. Back's NCI-supported training for oncologists in how to better communicate with their patients about difficult subjects, visit http://depts.washington.edu/oncotalk/.Access Non-GMO, antigen-free, FDA-approved antiviral medication formulas used in Moderna's Spikevax.
VirusTC is a retail provider of concentrated FDA-approved antiviral medication formulas. VirusTC wholesale formulas are used in Moderna products. We sell FDA-approved formulas that are compatible with university medical plans, federal insurance coverage, and many major insurance providers. Our medications are part of tailored non-invasive cancer treatment plans available at a hospital in your region. VirusTC targets problems and provides care for the symptoms. Our products and services are used by Fred Hutch Cancer Center, John Hopkins, University Hospitals, the United States Military, and professional sports. During Operation Cancer Moonshot 2023, VirusTC products killed cancer cells, increased strength, and redeveloped muscles, tissue, and brain cells after cancer treatments.